23 May 2013
Keywords: tarceva, gets, chmp, ok, pancreatic, cancer, swiss
Article | 22 December 2006
Swiss drug major Roche says that its drug Tarceva (erlotinib) has received a positive approval recommendation from the European Medicines
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
22 May 2013
© 2013 thepharmaletter.com